GADAVIST

Trials studying GADAVIST

• phase3A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patientsrecruitingn=640
• phase3A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesionsactive not recruitingn=309
• phase3A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesionsrecruitingn=250
• phase4Dotarem vs Gadobutrol Contrast for Breast MRIcompletedn=300
• phase4Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Yearsrecruitingn=2,076
• phase3A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)completedn=404
• phase3Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)completedn=324
• phase3Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)completedn=260